Precision Cancer Diagnostic Tests Market 2028 By Product Type, End User and Geography | The Insight Partners

Precision Cancer Diagnostic Tests Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Imaging, Molecular, Tumor Marker Immunoassays, POC Colon Cancer Tests); End User (Hospital, Clinic, Other) and Geography

Report Code: TIPRE00017625 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming

MARKET OVERVIEW

Precision Cancer Diagnostic Tests involves the imaging, in- vitro diagnostic testing and procedures which confirm and detect cancer progression and malignancies in patient's tissue sample. These precision cancer diagnostic tests also play a key part in cancer staging, making them extremely accurate and reliable. Precision cancer diagnostic tests are also used to track and evaluate a patient's ongoing cancer treatment, including whether or not the disease is responding to treatment. The rising prevalence of cancers, increasing demand for precision diagnostics for early detection of disease are expected to boost market growth during the forecast period.

MARKET SCOPE

The "Global Precision Cancer Diagnostic Tests Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the precision cancer diagnostic tests market with detailed market segmentation by product type and end user. The report provides key statistics on the market status of the leading precision cancer diagnostic tests market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on product type the market is segmented as, imaging, molecular, tumor marker immunoassays and POC colon cancer tests.
  •   Based on end user the market is segmented as, hospital, clinic and others.

MARKET DYNAMICS
Drivers:

  •   Increasing prevalences of cancers and malignancies across the globe.
  •   Rising demand for precision diagnostics for early detection of disease is expected to spur the market growth.
  •   Technological advancements in cancer diagnostics for accurate results is also expected to create significant growth opportunities for the market growth.

Restraints:

  •   Whereas, high cost of diagnostic imaging tests and presence of stringent regulatory framework are expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The precision cancer diagnostic tests market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the precision cancer diagnostic tests market in these regions.

IMPACT OF COVID-19 ON PRECISION CANCER DIAGNOSTIC TESTS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the precision cancer diagnostic tests market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from precision cancer diagnostic tests market are anticipated to lucrative growth opportunities in the future with the rising demand for precision cancer diagnostic tests in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the precision cancer diagnostic tests market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Abbott
  •   Agilent Technologies Inc.
  •   BD
  •   Bio-Rad Laboratories Inc.
  •   Biocartis
  •   bioMerieux SA
  •   MYRIAD ONCOLOGY
  •   Hologic Inc.
  •   QIAGEN
  •   Thermo Fisher Scientific

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Precision Cancer Diagnostic Tests Market - By Product Type
1.3.2 Precision Cancer Diagnostic Tests Market - By End User
1.3.3 Precision Cancer Diagnostic Tests Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PRECISION CANCER DIAGNOSTIC TESTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. PRECISION CANCER DIAGNOSTIC TESTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PRECISION CANCER DIAGNOSTIC TESTS MARKET - GLOBAL MARKET ANALYSIS
6.1. PRECISION CANCER DIAGNOSTIC TESTS - GLOBAL MARKET OVERVIEW
6.2. PRECISION CANCER DIAGNOSTIC TESTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. PRECISION CANCER DIAGNOSTIC TESTS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. IMAGING
7.3.1. Overview
7.3.2. Imaging Market Forecast and Analysis
7.4. MOLECULAR
7.4.1. Overview
7.4.2. Molecular Market Forecast and Analysis
7.5. TUMOR MARKER IMMUNOASSAYS
7.5.1. Overview
7.5.2. Tumor Marker Immunoassays Market Forecast and Analysis
7.6. POC COLON CANCER TESTS
7.6.1. Overview
7.6.2. POC Colon Cancer Tests Market Forecast and Analysis
8. PRECISION CANCER DIAGNOSTIC TESTS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis

9. PRECISION CANCER DIAGNOSTIC TESTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Precision Cancer Diagnostic Tests Market Overview
9.1.2 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.1.3 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.1.4 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.1.5 North America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.1.5.1 United States Precision Cancer Diagnostic Tests Market
9.1.5.1.1 United States Precision Cancer Diagnostic Tests Market by Product Type
9.1.5.1.2 United States Precision Cancer Diagnostic Tests Market by End User
9.1.5.2 Canada Precision Cancer Diagnostic Tests Market
9.1.5.2.1 Canada Precision Cancer Diagnostic Tests Market by Product Type
9.1.5.2.2 Canada Precision Cancer Diagnostic Tests Market by End User
9.1.5.3 Mexico Precision Cancer Diagnostic Tests Market
9.1.5.3.1 Mexico Precision Cancer Diagnostic Tests Market by Product Type
9.1.5.3.2 Mexico Precision Cancer Diagnostic Tests Market by End User
9.2. EUROPE
9.2.1 Europe Precision Cancer Diagnostic Tests Market Overview
9.2.2 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.2.3 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.2.4 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.2.5 Europe Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Precision Cancer Diagnostic Tests Market
9.2.5.1.1 Germany Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.1.2 Germany Precision Cancer Diagnostic Tests Market by End User
9.2.5.2 France Precision Cancer Diagnostic Tests Market
9.2.5.2.1 France Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.2.2 France Precision Cancer Diagnostic Tests Market by End User
9.2.5.3 Italy Precision Cancer Diagnostic Tests Market
9.2.5.3.1 Italy Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.3.2 Italy Precision Cancer Diagnostic Tests Market by End User
9.2.5.4 Spain Precision Cancer Diagnostic Tests Market
9.2.5.4.1 Spain Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.4.2 Spain Precision Cancer Diagnostic Tests Market by End User
9.2.5.5 United Kingdom Precision Cancer Diagnostic Tests Market
9.2.5.5.1 United Kingdom Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.5.2 United Kingdom Precision Cancer Diagnostic Tests Market by End User
9.2.5.6 Rest of Europe Precision Cancer Diagnostic Tests Market
9.2.5.6.1 Rest of Europe Precision Cancer Diagnostic Tests Market by Product Type
9.2.5.6.2 Rest of Europe Precision Cancer Diagnostic Tests Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Overview
9.3.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.3.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Precision Cancer Diagnostic Tests Market
9.3.5.1.1 Australia Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.1.2 Australia Precision Cancer Diagnostic Tests Market by End User
9.3.5.2 China Precision Cancer Diagnostic Tests Market
9.3.5.2.1 China Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.2.2 China Precision Cancer Diagnostic Tests Market by End User
9.3.5.3 India Precision Cancer Diagnostic Tests Market
9.3.5.3.1 India Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.3.2 India Precision Cancer Diagnostic Tests Market by End User
9.3.5.4 Japan Precision Cancer Diagnostic Tests Market
9.3.5.4.1 Japan Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.4.2 Japan Precision Cancer Diagnostic Tests Market by End User
9.3.5.5 South Korea Precision Cancer Diagnostic Tests Market
9.3.5.5.1 South Korea Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.5.2 South Korea Precision Cancer Diagnostic Tests Market by End User
9.3.5.6 Rest of Asia-Pacific Precision Cancer Diagnostic Tests Market
9.3.5.6.1 Rest of Asia-Pacific Precision Cancer Diagnostic Tests Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Precision Cancer Diagnostic Tests Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Precision Cancer Diagnostic Tests Market Overview
9.4.2 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.4.3 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Precision Cancer Diagnostic Tests Market
9.4.5.1.1 South Africa Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.1.2 South Africa Precision Cancer Diagnostic Tests Market by End User
9.4.5.2 Saudi Arabia Precision Cancer Diagnostic Tests Market
9.4.5.2.1 Saudi Arabia Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.2.2 Saudi Arabia Precision Cancer Diagnostic Tests Market by End User
9.4.5.3 U.A.E Precision Cancer Diagnostic Tests Market
9.4.5.3.1 U.A.E Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.3.2 U.A.E Precision Cancer Diagnostic Tests Market by End User
9.4.5.4 Rest of Middle East and Africa Precision Cancer Diagnostic Tests Market
9.4.5.4.1 Rest of Middle East and Africa Precision Cancer Diagnostic Tests Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Precision Cancer Diagnostic Tests Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Precision Cancer Diagnostic Tests Market Overview
9.5.2 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis
9.5.3 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By End User
9.5.5 South and Central America Precision Cancer Diagnostic Tests Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Precision Cancer Diagnostic Tests Market
9.5.5.1.1 Brazil Precision Cancer Diagnostic Tests Market by Product Type
9.5.5.1.2 Brazil Precision Cancer Diagnostic Tests Market by End User
9.5.5.2 Argentina Precision Cancer Diagnostic Tests Market
9.5.5.2.1 Argentina Precision Cancer Diagnostic Tests Market by Product Type
9.5.5.2.2 Argentina Precision Cancer Diagnostic Tests Market by End User
9.5.5.3 Rest of South and Central America Precision Cancer Diagnostic Tests Market
9.5.5.3.1 Rest of South and Central America Precision Cancer Diagnostic Tests Market by Product Type
9.5.5.3.2 Rest of South and Central America Precision Cancer Diagnostic Tests Market by End User

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PRECISION CANCER DIAGNOSTIC TESTS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AGILENT TECHNOLOGIES INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BD
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BIO-RAD LABORATORIES INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BIOCARTIS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIOMERIEUX SA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MYRIAD ONCOLOGY
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. HOLOGIC INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. QIAGEN
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. THERMO FISHER SCIENTIFIC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. Agilent Technologies Inc.
3. BD
4. Bio-Rad Laboratories Inc.
5. Biocartis
6. bioMerieux SA
7. MYRIAD ONCOLOGY
8. Hologic Inc.
9. QIAGEN
10. Thermo Fisher Scientific
TIPRE00017625
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount